TallyHQ
github
Client · LDA

GSK (FKA GLAXOSMITHKLINE INC.)

6 filings 84 bills mentioned 1 registrants 5 quarters ~$7,260,000 reported
Client ID
121722

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

S 43
Skinny Labels, Big Savings Act
CPT
6
S 1040
Drug Competition Enhancement Act
CPT
6
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
CPT
6
S 708
RESTORE Patent Rights Act of 2025
CPT
6
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HCR
6
S 891
Bipartisan Health Care Act
HCR
6
HR 1574
RESTORE Patent Rights Act of 2025
CPT
6
HR 946
ORPHAN Cures Act
HCR
6
S 832
EPIC Act of 2025
HCR
6
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
BUD
6
S 1041
Affordable Prescriptions for Patients Act
CPT
6
HR 2214
DRUG Act
HCR
6
S 1095
Stop STALLING Act
CPT
6
S 864
HELP Copays Act
BUDHCR
6
S 882
Patients Before Middlemen Act
HCR
5
HR 890
Stopping Pharma’s Ripoffs and Drug Savings For All Act
CPT
5
S 1097
Interagency Patent Coordination and Improvement Act of 2025
CPT
5
HR 1262
Mikaela Naylon Give Kids a Chance Act
HCR
4
S 1414
Expedited Access to Biosimilars Act
HCR
4
S 1546
Patent Eligibility Restoration Act of 2025
CPT
4
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
BUDHCRMMM
4
HR 3944
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
BUD
4
S 2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
BUD
4
S 652
Protecting Patients from Deceptive Drug Ads Act
HCR
4
S 1553
PREVAIL Act
CPT
4
S 932
Give Kids a Chance Act of 2025
HCR
4
HR 3152
Patent Eligibility Restoration Act of 2025
CPT
4
HR 3160
PREVAIL Act
CPT
4
HR 3269
ETHIC Act
CPT
4
HR 4213
Department of Homeland Security Appropriations Act, 2026
BUD
4
HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
BUD
4
S 1302
Increasing Transparency in Generic Drug Applications Act
CPTHCR
3
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
BUD
3
HR 4132
Prescription Information Modernization Act of 2025
HCR
3
S 1954
Biosimilar Red Tape Elimination Act
HCR
3
S 2658
Medication Affordability and Patent Integrity Act
CPTHCR
3
S 2620
REMEDY Act
CPT
3
HRES 566
Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14.
BUD
3
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
BUD
3
S 2296
National Defense Authorization Act for Fiscal Year 2026
BUDHCRTRD
3
HR 4570
Interagency Patent Coordination and Improvement Act of 2025
CPT
3
S 1784
MAPS Act
CPTHCR
3
S 2354
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
BUD
3
HR 6283
FOSTER Act
HCR
3
HR 5342
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026
BUD
3
S 2276
ETHIC Act
CPT
3
HR 6485
Skinny Labels, Big Savings Act
CPT
2
HR 5371
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
BUD
2
S 1637
MVP Act
MMM
2
HR 5256
340B ACCESS Act
HCR
2

Registrants

Lobbying firms that filed on behalf of this client.

GSK (FKA GLAXOSMITHKLINE INC.) 6

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.